A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Fayetteville, Arkansas, United States
- Research Site
Fresno, California, United States
- Research Site
Denver, Colorado, United States
- Research Site
New Haven, Connecticut, United States
- Research Site
Daytona Beach, Florida, United States
- Research Site
Lecanto, Florida, United States
- Research Site
North Port, Florida, United States
- Research Site
Sarasota, Florida, United States
- Research Site
Decatur, Illinois, United States
- Research Site
Las Vegas, Nevada, United States
- Research Site
New York, New York, United States
- Research Site
Durham, North Carolina, United States
- Research Site
Oklahoma City, Oklahoma, United States
- Research Site
Philadelphia, Pennsylvania, United States
- Research Site
Myrtle Beach, South Carolina, United States
- Research Site
Chattanooga, Tennessee, United States
- Research Site
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jun 2016
- Primary completion
- 31 Dec 2020
- Completion
- 31 Mar 2023
- Last update posted
- 26 May 2023
- Registered enrollment
- 313
- Registry id
- NCT02740985
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.